Potential of Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Potential of Clinical Trials in Brazil

Potential of Clinical Trials in Brazil – Cohortias the CRO of LATAM

Clinical trials are at the forefront of medical research, driving innovation and improving patient care. Brazil, with its vast population, advanced healthcare infrastructure, and supportive regulatory framework, holds immense potential as a destination for conducting clinical trials.

This blog explores the opportunities and advantages that clinical trials offer in Brazil, paving the way for medical breakthroughs, economic growth, and better health outcomes for its citizens.

Vast and Diverse Population

Brazil’s population of over 210 million people represents a rich tapestry of ethnicities, cultures, and genetic backgrounds. This diversity provides researchers with a unique advantage in conducting clinical trials, allowing for a broader understanding of treatment responses and population-specific variations.

By encompassing this diversity, trials in Brazil can generate valuable data that leads to more precise and targeted healthcare interventions, ensuring personalized treatment plans that cater to individual needs.

Advanced Healthcare Infrastructure

Brazil boasts a robust healthcare infrastructure, comprising cutting-edge medical facilities, research centers, and academic institutions. The country is home to prestigious medical schools and hospitals, attracting top-notch healthcare professionals and researchers.

The advanced infrastructure not only facilitates the implementation of clinical trials but also promotes collaboration between national and international stakeholders, fostering knowledge exchange and scientific advancements that benefit both Brazil and the global medical community.

Supportive Regulatory Framework

Brazil has made significant strides in establishing a supportive regulatory framework for clinical trials. The National Health Surveillance Agency (ANVISA) oversees the regulation and approval process, ensuring the highest standards of patient safety and ethical conduct.

The streamlined regulatory processes and transparent guidelines have led to increased efficiency and shorter approval timelines. This regulatory environment has attracted global pharmaceutical companies and research organizations to conduct trials in Brazil, further enhancing the country’s position in the global clinical research landscape.

Potential of Clinical Trials in Brazil

Potential of Clinical Trials in Brazil

Potential of Clinical Trials in Brazil

Access to Diverse Patient Cohorts

Brazil’s large and diverse population provides researchers with access to a wide range of patient cohorts, making it an ideal location for clinical trials. The inclusion of diverse participants from various socioeconomic backgrounds allows for comprehensive data collection and analysis, leading to a deeper understanding of treatment efficacy and potential side effects across different population subgroups.

This inclusivity ensures that clinical trials conducted in Brazil produce robust and representative results, enhancing the generalizability of research findings.


Brazil offers a cost-effective environment for conducting clinical trials, providing an attractive option for sponsors and researchers. Lower operational costs, including site expenses, labor, and administrative expenses, make Brazil an economically viable destination for trials.

Additionally, Brazil’s well-established healthcare system enables efficient patient recruitment and retention, further optimizing trial timelines and reducing costs. This cost advantage, combined with the quality of research facilities and patient access, positions Brazil as a highly competitive location for clinical research.

Scientific Collaboration and Knowledge Sharing

Clinical trials in Brazil foster scientific collaboration and knowledge sharing among researchers, healthcare professionals, and the broader scientific community. Collaborative efforts between national and international experts enable the exchange of expertise, innovative ideas, and research methodologies.

This collaboration contributes to capacity building and the development of local research talent, elevating Brazil’s research capabilities. Furthermore, knowledge sharing enhances the nation’s research ecosystem, enabling advancements in medical science, and ultimately benefiting the health and well-being of its population.

Economic Growth and Job Creation

The potential impact of clinical trials on Brazil’s economy is significant. Increased clinical trial activity attracts investment, stimulates local economies, and creates job opportunities across various sectors. The growth of clinical research centers and associated infrastructure generates employment for healthcare professionals, researchers, clinical trial coordinators, data analysts, and support staff.

This job creation not only contributes to economic growth but also strengthens the healthcare industry by fostering a skilled workforce. Additionally, clinical trials attract foreign investment, promoting technological advancements and the transfer of knowledge and expertise into the country.

The resulting economic benefits extend beyond the trial period, creating a ripple effect that positively impacts the overall healthcare system and the nation’s economy.

Improved Healthcare Outcomes

By conducting clinical trials in Brazil, researchers have the opportunity to address the specific healthcare needs of the local population. This approach considers genetic, environmental, and cultural factors that influence treatment responses, leading to improved healthcare outcomes.

Clinical trials offer Brazilian patients access to cutting-edge treatments and therapies that may otherwise be unavailable. Participation in trials not only benefits individual patients but also contributes to the advancement of medical science, as the knowledge gained from these trials informs future treatment protocols, guidelines, and healthcare practices.

Potential of Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Potential of Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Potential of Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Potential of Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Potential of Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Potential of Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Potential of Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Potential of Clinical Trials in Brazil

The Cohortias Team

Potential of Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Potential of Clinical Trials in Brazil

Network & Partnerships